Unique Liquid Chromatography Technique for Determining a New Selective PPARα Modulator Drug (Pemafibrate) in the Tablet Dosage Form, Robustness by Design Expert in the Light of Quality by Design

Documenti analoghi

• Estimation of Antimicrobial Agent (Sorbic Acid) in Semisolid Dosage Form (Gel) Using Liquid Chromatography and Evaluation of Its Stability in the Presence of Steroids, Polymers, and Low pH
  di: Naresh Konduru, et al.
  Pubblicazione: (2026)
• Quality by Design‐Based Development of a Robust LC Method for Simultaneous Estimation of Process‐ and Degradation‐Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent Tuberculosis
  di: Siva Prasad Korikana, et al.
  Pubblicazione: (2026)
• Multiple Reaction Monitoring LC‐MS/MS Quantification of N‐Nitrosamine Drug Substance Related Impurities of Clonidine in Drug Substance and in Tablet Dosage Form
  di: Bhaskar Vallamkonda, et al.
  Pubblicazione: (2025)
• Quality by Design Based Chromatography Technique Development and Validation for the Medicine Venetoclax (for Chronic Leukemia), in the Context of Impurities Including Degradation Products
  di: Rajeshwari Dandabattina, et al.
  Pubblicazione: (2025)
• Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms
  di: Prasanna Kumar Lankalapalli, et al.
  Pubblicazione: (2025)